Unlearn AI

Unlearn.AI specializes in using AI to generate synthetic data for clinical trials in the pharmaceutical and healthcare industries.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

About Us

Unlearn.AI develops artificial intelligence (AI) technology to create digital twins of clinical trial participants. These digital twins are virtual models that predict patient health outcomes over time. The company uses this technology to streamline and accelerate clinical trials, reducing the number of participants needed in control groups and potentially speeding up the drug development process.

Latest Articles in AI